Decoding cancer heterogeneity: Using an information-theoretic approach to design patient-specific drug combinations

Nataly Kravchenko-Balasha

Hebrew University of Jerusalem

POSITION TITLE: Senior lecturer (assistant professor), The Hebrew University of JerusalemEDUCATION:- B.Sc. The Hebrew University of Jerusalem (HUJI) 06/2004Biology and Mathematics Participated in Honors Program “AMIRIM” for outstanding students of the School of Science; and the “ETGAR” Honors Program, a special study track for outstanding students in biology.            - M.Sc. The Hebrew University of Jerusalem (HUJI) 06/2005 Biochemistry (as part of a direct PhD track)- PhD The Hebrew University of Jerusalem (HUJI) 11/2010Biochemistry- postdoctoral researcher (HUJI) 06/2011Theoretical Chemistry - postdoctoral researcher California Institute of Technology (Caltech), U.S.06/2015Biophysical Chemistry, EMBO fellow


IntroductionWorld-wide attempts are invested, aiming to develop effective strategies for personalized cancer medicine. We study a proteomic dataset obtained from ~3500 patients of 11 types. We aim to explore the data space of... [ view full abstract ]


  1. Efrat Flashner-Abramson (Hebrew University of Jerusalem)
  2. Nataly Kravchenko-Balasha (Hebrew University of Jerusalem)

Topic Areas

Drug target discovery and integration with individualized therapy, integration of diagnosi , Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et , Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions


OS3a-A » Drug target discovery and integration with individualized therapy / theragnosis (14:30 - Wednesday, 27th June, Amphitheater)

Presentation Files

The presenter has not uploaded any presentation files.